Related references
Note: Only part of the references are listed.Fabry disease pain: patient and preclinical parallels
Anthony J. Burand et al.
PAIN (2021)
Fabry disease-associated globotriaosylceramide induces mechanical allodynia via activation of signaling through proNGF-p75NTR but not mature NGF-TrkA
Junya Sugimoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Assessment of small fiber neuropathy in patients carrying the non-classical Fabry variant p.D313Y
Katharina von Cossel et al.
MUSCLE & NERVE (2021)
Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing
Jakob M. Domm et al.
MOLECULAR GENETICS AND METABOLISM (2021)
Fabry disease exacerbates renal interstitial fibrosis after unilateral ureteral obstruction via impaired autophagy and enhanced apoptosis
Sungjin Chung et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2021)
Fabry disease genotype, phenotype, and migalastat amenability: Insights from a national cohort
Albina Nowak et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
Globotriaosylceramide-induced reduction of KCa1.1 channel activity and activation of the Notch1 signaling pathway in skin fibroblasts of male Fabry patients with pain
Vanessa Rickert et al.
EXPERIMENTAL NEUROLOGY (2020)
Understanding the biopsychosocial factors contributing to mental health issues in Fabry disease: One tertiary centre experience
Stuart Forshaw-Hulme et al.
MOLECULAR GENETICS AND METABOLISM (2020)
Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and pain
Simon Korver et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Bridging the Gap Between Vessels and Nerves in Fabry Disease
Julia Forstenpointner et al.
FRONTIERS IN NEUROSCIENCE (2020)
Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review
Karolina M. Stepien et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Depression, sleep disturbances, pain, disability and quality of LIFE in Brazilian Fabry disease patients
Nilton Salles Rosa Neto et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2020)
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study
Dominique P. Germain et al.
GENETICS IN MEDICINE (2019)
Dyshidrosis is associated with reduced amplitudes in electrically evoked pain-related potentials in women with Fabry disease
Gabriela Siedlera et al.
CLINICAL NEUROPHYSIOLOGY (2019)
Tumor necrosis factor-α links heat and inflammation with Fabry pain
Nurcan Ueceyler et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study
Maarten Arends et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review
M. Chincholkar
BRITISH JOURNAL OF ANAESTHESIA (2018)
Fabry disease revisited: Management and treatment recommendations for adult patients
Alberto Ortiz et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial
Raphael Schiffmann et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Signatures of Altered Gene Expression in Dorsal Root Ganglia of a Fabry Disease Mouse Model
Kai K. Kummer et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Nerve Growth Factor and Pathogenesis of Leprosy: Review and Update
Tinara Leila de Souza Aarao et al.
FRONTIERS IN IMMUNOLOGY (2018)
Dorsal root ganglia in vivo morphometry and perfusion in female patients with Fabry disease
Tim Godel et al.
JOURNAL OF NEUROLOGY (2018)
Cannabinoids and Pain: New Insights From Old Molecules
Sonja Vuckovic et al.
FRONTIERS IN PHARMACOLOGY (2018)
Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement
Nicolas Guerard et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Neuropathic pain in a Fabry disease rat model
James J. Miller et al.
JCI INSIGHT (2018)
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study
Maarten Arends et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Analgesic Mechanisms of Antidepressants for Neuropathic Pain
Hideaki Obata
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Contribution of inflammatory pathways to Fabry disease pathogenesis
Paula Rozenfeld et al.
MOLECULAR GENETICS AND METABOLISM (2017)
New technologies for the assessment of neuropathies
Roberto Gasparotti et al.
NATURE REVIEWS NEUROLOGY (2017)
THE TrKA RECEPTOR MEDIATES EXPERIMENTAL THERMAL HYPERALGESIA PRODUCED BY NERVE GROWTH FACTOR: MODULATION BY THE p75 NEUROTROPHIN RECEPTOR
Alla Khodorova et al.
NEUROSCIENCE (2017)
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy
Rocco Liguori et al.
PLOS ONE (2017)
Changes in Ionic Conductance Signature of Nociceptive Neurons Underlying Fabry Disease Phenotype
Barbara Namer et al.
FRONTIERS IN NEUROLOGY (2017)
Physical activity and the mediating effect of fear, depression, anxiety, and catastrophizing on pain related disability in people with chronic low back pain
Paul W. M. Marshall et al.
PLOS ONE (2017)
X-chromosome inactivation in female patients with Fabry disease
L. Echevarria et al.
CLINICAL GENETICS (2016)
Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment
Juan M. Politei et al.
CNS NEUROSCIENCE & THERAPEUTICS (2016)
Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease
Nurcan Ueceyler et al.
PLOS ONE (2016)
Enzyme replacement therapy for Anderson-Fabry disease
Regina El Dib et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
Dominique P. Germain et al.
JOURNAL OF MEDICAL GENETICS (2015)
The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain
L. Choi et al.
NEUROSCIENCE LETTERS (2015)
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
Marieke Biegstraaten et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Newborn screening for lysosomal storage disorders
Dietrich Matern et al.
SEMINARS IN PERINATOLOGY (2015)
Characterization of Pain in Fabry Disease
Nurcan Ueceyler et al.
CLINICAL JOURNAL OF PAIN (2014)
Pain Related Channels Are Differentially Expressed in Neuronal and Non-Neuronal Cells of Glabrous Skin of Fabry Knockout Male Mice
Jarmila Lakoma et al.
PLOS ONE (2014)
Cutaneous Vasodilator and Vasoconstrictor Mechanisms in Temperature Regulation
John M. Johnson et al.
COMPREHENSIVE PHYSIOLOGY (2014)
Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study
Nurcan Uceyler et al.
BMC NEUROLOGY (2013)
Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management
Laura McKelvey et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Fabry disease peripheral blood immune cells release inflammatory cytokines: Role of globotriaosylceramide
Pablo N. De Francesco et al.
MOLECULAR GENETICS AND METABOLISM (2013)
NERVE GROWTH FACTOR/P75 NEUROTROPHIN RECEPTOR-MEDIATED SENSITIZATION OF RAT SENSORY NEURONS DEPENDS ON MEMBRANE CHOLESTEROL
Y. H. Zhang et al.
NEUROSCIENCE (2013)
Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy
Giovana B. Biancini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Prevalence of symptoms in female Fabry disease patients: a case-control survey
Machtelt G. Bouwman et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
Upregulation of inward rectifying currents and Fabry disease neuropathy
Nimeshan Geevasinga et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2012)
Small fiber neuropathy in Fabry disease
Marieke Biegstraaten et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Fabry disease
Dominique P. Germain
ORPHANET JOURNAL OF RARE DISEASES (2010)
Fabry disease: a review of current management strategies
A. Mehta et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Social-adaptive and psychological functioning of patients affected by Fabry disease
Dawn Alyssia Laney et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Re-emerging microneurography
J. Serra
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Lysosomal storage disease 3 - Fabry's disease
Yuri A. Zarate et al.
LANCET (2008)
Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells
Jin-Song Shen et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Depression in adults with Fabry disease: A common and under-diagnosed problem
A. L. Cole et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy - A retrospective analysis from the Fabry outcome survey
Bjoern Hoffmann et al.
CLINICAL JOURNAL OF PAIN (2007)
Psychophysics, flare, and neurosecretory function in human pain models:: Capsaicin versus electrically evoked pain
Christian Geber et al.
JOURNAL OF PAIN (2007)
Neurological manifestations in Fabry's disease
Anette T Moller et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2007)
Enzyme replacement therapy with agalsidase alfa in children with Fabry disease
U. Ramaswami et al.
ACTA PAEDIATRICA (2007)
Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life
Barry Halliwell
PLANT PHYSIOLOGY (2006)
Enzyme replacement therapy improves function of C-, Aδ-, and Aβ-nerve fibers in Fabry neuropathy
MJ Hilz et al.
NEUROLOGY (2004)
Monitoring the 3-year efficacy of enzyme replacement therapy in Fabry disease by repeated skin biopsies
BL Thurberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor
YH Zhang et al.
NEUROSCIENCE LETTERS (2004)
Functional assessment of Aδ and C fibers in patients with Fabry's disease
M Valeriani et al.
MUSCLE & NERVE (2004)
Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease
R Schiffmann et al.
MUSCLE & NERVE (2003)
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females
KD MacDermot et al.
JOURNAL OF MEDICAL GENETICS (2001)
A phase 1/2 clinical trial of enzyme replacement in Fabry disease: Pharmacokinetic, substrate clearance, and safety studies
CM Eng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Anticonvulsants for neuropathic pain syndromes - Mechanisms of action and place in therapy
IW Tremont-Lukats et al.
DRUGS (2000)
Share Paper
